AI assistant
Emergent BioSolutions Inc. — Director's Dealing 2016
Apr 8, 2016
32870_dirs_2016-04-08_c259b288-50e5-4b2d-87ca-50e9c4a67997.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2016-04-06
Reporting Person: Kramer Robert (EVP, Corporate Services Divisi)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-04-06 | Common Stock | M | 5765 | $14.41 | Acquired | 77551 | Direct |
| 2016-04-06 | Common Stock | S | 5765 | $38.90 | Disposed | 71786 | Direct |
| 2016-04-06 | Common Stock | M | 1970 | $14.67 | Acquired | 73756 | Direct |
| 2016-04-06 | Common Stock | S | 1970 | $38.90 | Disposed | 71786 | Direct |
| 2016-04-06 | Common Stock | M | 8677 | $28.09 | Acquired | 80463 | Direct |
| 2016-04-06 | Common Stock | S | 8677 | $38.90 | Disposed | 71786 | Direct |
| 2016-04-06 | Common Stock | M | 2751 | $29 | Acquired | 74537 | Direct |
| 2016-04-06 | Common Stock | S | 2751 | $38.90 | Disposed | 71786 | Direct |
| 2016-04-06 | Common Stock | S | 2623 | $38.90 | Disposed | 69163 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-04-06 | Stock Option | $14.41 | M | 5765 | Acquired | 2019-11-04 | Common Stock (5765) | Direct |
| 2016-04-06 | Stock Option | $14.67 | M | 1970 | Acquired | 2020-03-11 | Common Stock (1970) | Direct |
| 2016-04-06 | Stock Option | $28.09 | M | 8677 | Acquired | 2021-03-10 | Common Stock (8677) | Direct |
| 2016-04-06 | Stock Option | $29 | M | 2751 | Acquired | 2022-03-09 | Common Stock (2751) | Direct |
Footnotes
F1: Consists of an option granted under the company's stock incentive plan on November 5, 2012.
F2: Consists of an option granted under the company's stock incentive plan on March 12, 2013.
F3: Consists of an option granted under the company's stock incentive plan on March 11, 2014.
F4: Consists of an option granted under the company's stock incentive plan on March 10, 2015.
F5: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kramer.
F6: Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
F7: The option vested in three equal installments in November 2013, 2014 and 2015.
F8: The option vest in three equal installments in March 2014, 2015 and 2016.
F9: The option vest in three equal installments in March 2015, 2016 and 2017.
F10: The option vest in three equal installments in March 2016, 2017 and 2018.